Evidence map›Paper›PMID 24554717›Full record

ArticleThe Journal of biological chemistry2014

Defective craniofacial development and brain function in a mouse model for depletion of intracellular inositol synthesis.

Tetsuo Ohnishi, Takuya Murata, Akiko Watanabe, Akiko Hida, Hisako Ohba, Yoshimi Iwayama, Kazuo Mishima, Yoichi Gondo, Takeo Yoshikawa

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ebselen has lithium-like effects on central 5-HTBritish journal of pharmacology · 2018
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Tetsuo OhnishiLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198. Electronic address: tohnishi@brain.riken.jp.
Takuya MurataMutagenesis and Genomics Team, RIKEN BioResource Center, Tsukuba, Ibaraki 305-0074.
Akiko WatanabeLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198.
Akiko HidaDepartment of Psychophysiology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan.
Hisako OhbaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198.
Yoshimi IwayamaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198.
Kazuo MishimaDepartment of Psychophysiology, National Institute of Mental Health, National Center of Neurology and Psychiatry, Kodaira, Tokyo 187-8553, Japan.
Yoichi GondoMutagenesis and Genomics Team, RIKEN BioResource Center, Tsukuba, Ibaraki 305-0074.
Takeo YoshikawaLaboratory for Molecular Psychiatry, RIKEN Brain Science Institute, Wako, Saitama 351-0198.
RIKEN Center for Brain Science · JPNational Institute of Mental Health · JPRIKEN BioResource Research Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

myo-Inositol is an essential biomolecule that is synthesized by myo-inositol monophosphatase (IMPase) from inositol monophosphate species. The enzymatic activity of IMPase is inhibited by lithium, a drug used for the treatment of mood swings seen in bipolar disorder. Therefore, myo-inositol is thought to have an important role in the mechanism of bipolar disorder, although the details remain elusive. We screened an ethyl nitrosourea mutant mouse library for IMPase gene (Impa) mutations and identified an Impa1 T95K missense mutation. The mutant protein possessed undetectable enzymatic activity. Homozygotes died perinatally, and E18.5 embryos exhibited striking developmental defects, including hypoplasia of the mandible and asymmetric fusion of ribs to the sternum. Perinatal lethality and morphological defects in homozygotes were rescued by dietary myo-inositol. Rescued homozygotes raised on normal drinking water after weaning exhibited a hyper-locomotive trait and prolonged circadian periods, as reported in rodents treated with lithium. Our mice should be advantageous, compared with those generated by the conventional gene knock-out strategy, because they carry minimal genomic damage, e.g. a point mutation. In conclusion, our results reveal critical roles for intracellular myo-inositol synthesis in craniofacial development and the maintenance of proper brain function. Furthermore, this mouse model for cellular inositol depletion could be beneficial for understanding the molecular mechanisms underlying the clinical effect of lithium and myo-inositol-mediated skeletal development.

Indexed as

Amino Acid SequenceAnimalsBehavior, AnimalBipolar DisorderBrainBrain DiseasesCircadian RhythmDisease Models, AnimalEthylnitrosoureaFemaleGene LibraryGenotypeHomozygoteHumansInositolLithiumEthylnitrosoureaInositolLithiummyo-inositol-1 (or 4)-monophosphatasePhosphoric Monoester HydrolasesRecombinant ProteinsBoneBrainCircadian RhythmsCraniofacial DevelopmentInositol PhosphatesMouse GeneticsMutagenesisNeurodevelopmentPhosphatase

Identifiers

PMID24554717
PMCPMC4036449
OpenAlexW2062847124

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.